Merck gained 1.56% to Rs 338.55 at 15:22 IST on BSE after posting 1.61% rise in net profit to Rs 16.19 crore in Q1 March 2008 over Q1 March 2007.
The stock hit a high of Rs 348 and a low of Rs 334.05 so far during the day. The stock had a 52-week high of Rs 460 on
The company’s current equity is Rs 16.86 crore. Face value per share is Rs 10.
The current price of Rs 338.55 discounts its Q4 December 2007 EPS of Rs 41.33, by a PE multiple of 8.19.
Merck’s sales rose 18.40% to Rs 83.63 crore in Q1 March 2008 over Q1 March 2007.
Merck is engaged in manufacturing and marketing pharmaceuticals and chemicals. Pharmaceuticals include antibiotics, anti-malarials, cardiologicals, cough and cold formulations, dermatologicals, haematinics, neurologicals, oral rehydration salts and non-steroidal anti-inflammatory drugs. Chemicals include pigments and chemicals that are used in the cosmetics, health and nutrition industries. The group also manufactures and markets tablet, capsules, reagents, kits, equipment, paper rolls and booklets.
No comments:
Post a Comment